A live Mycoplasma synoviae vaccine that holds an EU wide Marketing Authorisation and is currently marketed by us in 19 countries including Ukraine and Jordan. In some Middle Eastern and African countries, MS-H is marketed under the name of Vaxsafe MS ®
Vaxsafe® MG is a live attenuated Mycoplasma gallisepticum (MG) vaccine based on the temperature-sensitive ts-11 strain, developed to support the control of MG-associated chronic respiratory disease in poultry. With a well-established safety and efficacy profile, Vaxsafe® MG has been widely used in poultry vaccination programmes and is available in selected markets where it is registered for use
Calpid D+ A synergistic solution: Simultaneous Calcium Pidolate and Vitamin Hy-D® treatment
Please select both a country and product from the dropdowns.
Please select both a country and product from the dropdowns.
There has been some sort of technical error with the submission. Please try again.
Sorry but there are no matches for that combination.